1-7 of 7
Ju-Seog Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors

Takahito M. Miyake, Sunila Pradeep, Emine Bayraktar, Elaine Stur, Katelyn F. Handley, Sherry Y. Wu, Cristian Rodriguez-Aguayo, Ju-Seog Lee, Gabriel Lopez-Berestein, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (8): 1727–1735.
https://doi.org/10.1158/1535-7163.MCT-19-0977
Published: 04 August 2020
View article titled, NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors
Open the PDF for NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors in another window
Includes: Supplementary data
Journal Articles

PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

Takeshi Hisamatsu, Michael McGuire, Sherry Y. Wu, Rajesha Rupaimoole, Sunila Pradeep, Emine Bayraktar, Kyunghee Noh, Wei Hu, Jean M. Hansen, Yasmin Lyons, Kshipra M. Gharpure, Archana S. Nagaraja, Lingegowda S. Mangala, Takashi Mitamura, Cristian Rodriguez-Aguayo, Young Gyu Eun, Johnathon Rose, Geoffrey Bartholomeusz, Cristina Ivan, Ju-Seog Lee, Koji Matsuo, Michael Frumovitz, Kwong K. Wong, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (1): 162–172.
https://doi.org/10.1158/1535-7163.MCT-17-1050
Published: 02 January 2019
View article titled, <em>PRKRA</em>/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer
Open the PDF for <em>PRKRA</em>/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B197: Selective depletion of YAP1 with next-generation antisense oligonucleotides leads to immune cell infiltration and tumor regression in mouse models of HCC

Youngsoo Kim, Joanna Schmidt, Minji Jo, Jing Yi, Tianyuan Zhou, Xiaolin Luo, Sun Young Yim, Ju-Seog Lee, Randy L. Johnson, Brett P. Monia, Gordon Mills, A. Robert MacLeod
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): B197.
https://doi.org/10.1158/1535-7163.TARG-17-B197
Published: 01 January 2018
View article titled, Abstract B197: Selective depletion of YAP1 with next-generation antisense oligonucleotides leads to immune cell infiltration and tumor regression in mouse models of HCC
Journal Articles

Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters

KyoungHyun Kim, Gayathri Chadalapaka, Satya S. Pathi, Un-Ho Jin, Ju-Seog Lee, Yun-Yong Park, Sung-Gook Cho, Sudhakar Chintharlapalli, Stephen Safe
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (9): 1852–1862.
https://doi.org/10.1158/1535-7163.MCT-12-0181
Published: 06 September 2012
View article titled, Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
Open the PDF for Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters in another window
Includes: Supplementary data
Journal Articles

Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models

Jae-Ho Cheong, Eun Sung Park, Jiyong Liang, Jennifer B. Dennison, Dimitra Tsavachidou, Catherine Nguyen-Charles, Kwai Wa Cheng, Hassan Hall, Dong Zhang, Yiling Lu, Murali Ravoori, Vikas Kundra, Jaffer Ajani, Ju-Seog Lee, Waun Ki Hong, Gordon B. Mills
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (12): 2350–2362.
https://doi.org/10.1158/1535-7163.MCT-11-0497
Published: 07 December 2011
View article titled, Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
Open the PDF for Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models in another window
Includes: Supplementary data
Journal Articles

Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set

Eun Sung Park, Rosalia Rabinovsky, Mark Carey, Bryan T. Hennessy, Roshan Agarwal, Wenbin Liu, Zhenlin Ju, Wanleng Deng, Yiling Lu, Hyun Goo Woo, Sang-Bae Kim, Jae-Ho Cheong, Levi A. Garraway, John N. Weinstein, Gordon B. Mills, Ju-Seog Lee, Michael A. Davies
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (2): 257–267.
https://doi.org/10.1158/1535-7163.MCT-09-0743
Published: 09 February 2010
View article titled, Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
Open the PDF for Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set in another window
Includes: Supplementary data
Journal Articles

Abstract C163: Gene expression signature‐based Connectivity Map analysis revealed vorinostat as a novel therapeutic target agent in human gastric cancer

Sofie A. Claerhout, Jae Yun Lim, Woonyoung Choi, Sang‐Bae Kim, Yun‐Yong Park, KyoungHyun Kim, Gordon B. Mills, Waun Ki Hong, Ju‐Seog Lee, Jae Yong Cho
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C163.
https://doi.org/10.1158/1535-7163.TARG-09-C163
Published: 10 December 2009
View article titled, Abstract C163: Gene expression signature‐based Connectivity Map analysis revealed vorinostat as a novel therapeutic target agent in human gastric cancer